225 related articles for article (PubMed ID: 17124778)
1. Engineering allergens.
Mutschlechner S; Ferreira F
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):226-9. PubMed ID: 17124778
[No Abstract] [Full Text] [Related]
2. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D
Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
[No Abstract] [Full Text] [Related]
3. [Rapid hyposensitization].
Krankenpfl J; 2004; 42(1-2):24-5. PubMed ID: 15116774
[No Abstract] [Full Text] [Related]
4. LAIS Allergoid.
Mistrello G
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):21-4. PubMed ID: 17761102
[No Abstract] [Full Text] [Related]
5. Clinical experience with recombinant pollen allergens.
Cromwell O
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):245-6. PubMed ID: 17124784
[No Abstract] [Full Text] [Related]
6. Modifying allergens and using adjuvants for specific immunotherapy.
Larché M; Ferreira F; Mohapatra SS
Clin Allergy Immunol; 2004; 18():641-61. PubMed ID: 15042940
[No Abstract] [Full Text] [Related]
7. Specific immunotherapy--the induction of new IgE-specificities?
van Hage-Hamsten M; Valenta R
Allergy; 2002 May; 57(5):375-8. PubMed ID: 11972475
[No Abstract] [Full Text] [Related]
8. Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives.
Pauli G; Purohit A; Oster JP; de Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):216-7. PubMed ID: 10224385
[No Abstract] [Full Text] [Related]
9. Allergen-specific immunotherapy.
Niederberger V
Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and its persistence, in children and adults.
Di Rienzo V
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
[No Abstract] [Full Text] [Related]
11. [Allergens].
Guérin L; Veber C
Allerg Immunol (Paris); 1999 Apr; 31 Spec No():9-17. PubMed ID: 10379406
[TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapy, one century later.
Passalacqua G; Bush RK
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
[No Abstract] [Full Text] [Related]
13. Antibody-based methods for standardization of allergoids and recombinant hypoallergens.
Fiebig H; Kahlert H; Weber B; Suck R; Nandy A; Cromwell O
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():71-82; discussion 82-3. PubMed ID: 20799447
[No Abstract] [Full Text] [Related]
14. Clinical trials with recombinant allergens: research studies?
Pauli G
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
[No Abstract] [Full Text] [Related]
15. Standardization and efficacy of allergen extracts.
Lichtenstein LM
N Engl J Med; 1976 Nov; 295(21):1195-6. PubMed ID: 980024
[No Abstract] [Full Text] [Related]
16. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
[TBL] [Abstract][Full Text] [Related]
17. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F
Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519
[No Abstract] [Full Text] [Related]
18. [Recommendations for hyposensitization with allergen extracts. Medical Society of German Allergologists].
Sennekamp J; Kersten W; Fuchs E; Hornung B
Med Monatsschr Pharm; 1989 Oct; 12(10):315-8. PubMed ID: 2682154
[No Abstract] [Full Text] [Related]
19. Recombinant allergens: the future of the diagnosis and treatment of atopic allergy.
Kraft D; Ferreira F; Ebner C; Valenta R; Breiteneder H; Susani M; Breitenbach M; Scheiner O
Allergy; 1998; 53(45 Suppl):62-6. PubMed ID: 9788710
[No Abstract] [Full Text] [Related]
20. Molecular design of allergy vaccines.
Linhart B; Valenta R
Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
